This patient-centred guideline has been conceived and developed by the genetic haemochromatosis patient community under the auspices of Haemochromatosis UK, with expert clinician support, in response to the discontinuation by NICE of their guideline development process for Genetic Haemochromatosis in Adults (2023).
The guideline sets out :
- A framework for describing genetic haemochromatosis and iron overload in the clinical setting
- The role of genetic screening as a preventative healthcare approach
- Recommendations on population screening
- Recommendations on cascade screening
- Primary care diagnostic considerations in preventing patient harm from iron overload
- A summary of target treatment parameters for secondary care
First published in January 2025, copies will be despatched from 31st January 2025.
48 pages - ISBN : 978-1-0369-0742-6
The guideline is relevant to both clinicians and people living with genetic haemochromatosis.